Plus   Neg

Chemed Q4 Profit Tops Estimates; Revenue Up 6.2% - Quick Facts

Chemed Corp. (CHE) reported fourth-quarter adjusted EPS of $2.32, an increase of 10.5% from prior year. On average, three analysts polled by Thomson Reuters expected the company to report profit per share of $2.27 for the quarter. Analysts' estimates typically exclude special items.

Fourth-quarter revenue increased 6.2% to $428 million. Analysts expected revenue of $423.83 million for the quarter. Net revenue for VITAS was $292 million in the fourth quarter of 2017, which is an increase of 2.8%, when compared to the prior-year period.

The company's full-year 2018 adjusted earnings per share, excluding non-cash expense for stock options, costs related to litigation, and other discrete items, is estimated to be in the range of $10.60 to $10.85. Revenue growth for VITAS in 2018, prior to Medicare Cap, is estimated to be in the range of 2.5% to 3.5%. Roto-Rooter is forecasted to achieve full-year 2018 revenue growth of 4.0% to 5.0%.

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT